(Swedesboro, New Jersey—March 3, 2017) The American College of Veterinary Pharmacists
(ACVP) presented the 2017 Earl W. “Bill” Bradley Award to Lucy Malmberg, R.Ph., F.A.C.A., F.A.C.V.P., chairman of the board of Wedgewood Pharmacy. Wedgewood Pharmacy is the largest U.S. compounding pharmacy specializing in animal health.
The award is presented to a member of ACVP who has shown outstanding service to veterinary pharmacy; it has been awarded biennially since 2011. The presentation was made during the President’s Banquet on February 26.
The Earl W. ‘Bill’ Bradley Award was established in 2006 for Fellows of the American College of Veterinary Pharmacists. Bill Bradley served as president of the American College of Apothecaries from 1988-89 and played an integral role in the creation of the American College of Veterinary Pharmacists in 1998. At that time, Bradley already was a pioneer in veterinary compounding having opened a veterinary-only compounding pharmacy four years earlier. Over the years, Bradley has served the ACVP as president, director and primary instructor of the National Training Center Laboratory
Donnie R. Calhoun, R.Ph., F.A.C.A. executive vice president & CEO of ACVP said, "Lucy Malmberg has played an integral role in the development of veterinary compounding and its ability to improve the lives of our animal patients. On behalf of the Board of Directors of the American College of Veterinary Pharmacists, we thank Lucy for her contributions to pharmacy and her dedication to our profession. She is truly deserving of this honor."
Marcy Bliss, president and CEO of Wedgewood Pharmacy added, “Lucy’s career as a steward for the health of both people and animals has been extraordinary. She and her late husband, George, literally shaped the modern practice of veterinary compounding pharmacy. This award recognizes her many contributions to the pharmacy profession.”
Malmberg has more than 30 years' experience in the pharmacy profession. She is a registered pharmacist in Pennsylvania and Delaware. As co-founder of Wedgewood Pharmacy, she has been instrumental in transforming the company from a local community pharmacy purchased in 1981 into a specialized compounding pharmacy that is now one of the largest in the United States, serving more than 30,000 prescribers nationwide.
In 2002 Malmberg was a leader of the industry coalition of seven compounding pharmacies that argued successfully before the Supreme Court of the United States that the Food and Drug Administration Modernization Act of 1997 (FDAMA), which prohibited pharmacists from advertising or promoting compounded drugs, was a violation of their First Amendment rights. Since that time, Malmberg has continued to lead industry efforts to protect the right of licensed prescribers to prescribe, and licensed compounding pharmacists to provide, custom-made drugs to meet the unmet needs of individual patients.
In 2005 Malmberg was instrumental in forming the International Academy of Compounding Pharmacists' (IACP) public affairs task force, which created an advocacy program centered around Patients and Professionals for Customized Care (P2C2), a website that provides tools and information for advocates of compounding pharmacy to influence public policy.
Prior to Wedgewood Pharmacy, Malmberg was an executive at E.I. DuPont de Nemours & Company, Inc. in a variety of sales, marketing and business operations positions.
Malmberg is a past-member of the board of directors of the International Academy of Compounding Pharmacists and served on its Nominations Committee. She is a member of the Board of Trustees for the University of the Sciences, where she also serves on the Executive and Audit Committees and is Chair of the Advancement Committee.
She also is a member of the American Pharmacist Association and the National Community Pharmacists Association and is a Fellow of both the American College of Apothecaries and the American College of Veterinary Pharmacists. She was active with the American Red Cross of the Delmarva Peninsula from 1995-2001, holding titles of board member, board secretary, board vice chair and board chair.
In 2013 Malmberg was awarded the Evelyn Timmons, R.Ph., Advocacy Award by Professional Compounding Centers of America. In 1991 she received the DuPont Vice President's Award for Quality and Leadership, and in March 1993 the DuPont Engineering Award for her leadership and contributions to the Hotel DuPont project.
Malmberg holds a B.S. degree in Pharmacy from the Philadelphia College of Pharmacy at the University of the Sciences.
About Wedgewood Pharmacy
In its 36-year history, the company has grown from a local community pharmacy to become one of the largest compounding pharmacies in the United States, serving more than 30,000 prescribers and hundreds of thousands of patients throughout the U.S. every year with customized animal-health and human-health prescriptions. The company employs more than 300 people.
Wedgewood Pharmacy is accredited by Pharmacy Compounding Accreditation Board (PCAB®) for compliance with PCAB pharmacy compounding accreditation standards. PCAB is a service of Accreditation Commission for Health Care and is a third-party accreditation organization that has developed the highest national standards that providers are measured against in order to illustrate their ability to effectively and efficiently deliver quality compounded medications to consumers.
In June 2016, Chicago-based New Harbor Capital became the majority owner of the company.